Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Mesothelioma × Sunitinib × Clear all

Sponsor

Conditions

Carcinoma, Renal Cell 56 Breast Neoplasms 19 Kidney Neoplasms 16 Gastrointestinal Stromal Tumors 14 Neoplasms 12 Carcinoma, Non-Small-Cell Lung 9 Prostatic Neoplasms 8 Urinary Bladder Neoplasms 7 Neoplasm Metastasis 6 Colorectal Neoplasms 6 Brain Neoplasms 5 Thyroid Neoplasms 4 Stomach Neoplasms 4 Small Cell Lung Carcinoma 4 Ovarian Neoplasms 4 Neuroendocrine Tumors 4 Liver Neoplasms 4 Carcinoma, Hepatocellular 4 Carcinoma 4 Thyroid Cancer, Papillary 3 Sarcoma 3 Leukemia, Myelomonocytic, Chronic 3 Kidney Diseases 3 Glioblastoma 3 Esophageal Neoplasms 3 Clear-cell metastatic renal cell carcinoma 3 Astrocytoma 3 Adenoma, Islet Cell 3 Adenocarcinoma, Follicular 3 Urogenital Neoplasms 2

Interventions

Pemetrexed 11 Cisplatin 10 pembrolizumab 7 Carboplatin 6 Ipilimumab 5 Nivolumab 4 durvalumab 3 LMB-100 3 Gemcitabine 3 tremelimumab 2 tazemetostat 2 anetumab ravtansine 2 Vinorelbine 2 Plicamycin 2 Dexamethasone 2 Cyclophosphamide 2 Bevacizumab 2 vandetanib 1 tocilizumab 1 ribociclib 1 rebastinib 1 pevonedistat 1 olaparib 1 niraparib 1 nintedanib 1 fludarabine phosphate 1 fludarabine 1 epacadostat 1 enzalutamide 1 defactinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡